Spots Global Cancer Trial Database for salvage therapy
Every month we try and update this database with for salvage therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma | NCT00636311 | Hodgkin Disease | Ifosfamide, Gem... Bortezomib + IG... | 18 Years - 65 Years | Istituto Clinico Humanitas | |
| Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA | NCT01531205 | Prostate Cancer | Androgen Ablati... Cabazitaxel Salvage Therapy Neoadjuvant Tre... Neoadjuvant Tre... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors | NCT01966913 | Germ Cell Tumor | Bevacizumab ICE chemotherap... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA | NCT01531205 | Prostate Cancer | Androgen Ablati... Cabazitaxel Salvage Therapy Neoadjuvant Tre... Neoadjuvant Tre... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients | NCT03731442 | Esophageal Canc... | Involved field ... Elective field ... Paclitaxel Platinum PEG-rhG-CSF | 16 Years - 70 Years | ChineseAMS | |
| Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) | NCT03340129 | Melanoma Stage ... | Ipilimumab Nivolumab Stereotactic Ra... Salvage therapy | 18 Years - 120 Years | Melanoma Institute Australia | |
| A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma | NCT01412307 | Recurrent Adult... | Lenalidomide Bendamustine Bio-specimen Re... | 18 Years - | GiovanniPascale | |
| Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) | NCT03340129 | Melanoma Stage ... | Ipilimumab Nivolumab Stereotactic Ra... Salvage therapy | 18 Years - 120 Years | Melanoma Institute Australia | |
| A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms | NCT00001444 | Breast Cancer Lymphoma Neoplasm Prostatic Neopl... | 7-hydroxystauro... | - | National Institutes of Health Clinical Center (CC) | |
| Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer | NCT01583920 | Prostate Cancer | focal salvage H... | 18 Years - | Sunnybrook Health Sciences Centre | |
| Zanubrutinib+Lenalidomide+R-ICE in Relapsed/Refractory DLBCL | NCT06033820 | Diffuse Large B... Diffuse Large B... | ZR2-ICE | 18 Years - 75 Years | RenJi Hospital | |
| Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors | NCT01966913 | Germ Cell Tumor | Bevacizumab ICE chemotherap... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia | NCT06034561 | Acute Lymphobla... Acute Lymphobla... | Bortezomib | 16 Years - 60 Years | Instituto do Cancer do Estado de São Paulo | |
| Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer | NCT05450965 | Small-cell Lung... Small Cell Lung... | Onvansertib | 18 Years - | University of Maryland, Baltimore | |
| Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) | NCT03340129 | Melanoma Stage ... | Ipilimumab Nivolumab Stereotactic Ra... Salvage therapy | 18 Years - 120 Years | Melanoma Institute Australia | |
| A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms | NCT00001444 | Breast Cancer Lymphoma Neoplasm Prostatic Neopl... | 7-hydroxystauro... | - | National Institutes of Health Clinical Center (CC) | |
| Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer | NCT01426620 | Non-small Cell ... | Blueberry powde... | 18 Years - | University of Louisville | |
| Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents | NCT01535183 | Brain Tumor | Irinotecan comb... | - 19 Years | Seoul National University Hospital | |
| Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors | NCT01743482 | Germ Cell Tumor... Measurable Dise... | Pazopanib | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness | NCT05232578 | Prostate Cancer | Early salvage r... Delayed Salvage... | 18 Years - | General University Hospital, Prague |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
